| Financial Year |
March 31 2023 |
| Monetary Funds |
489,995,625.54 |
| Held-for-trading Financial Assets |
73,127,097.26 |
| Notes Receivable |
23,964,379.09 |
| Accounts Receivable |
2,301,053,884.97 |
| Advances to Suppliers |
799,489,267.24 |
| Other Receivables |
1,410,046,720.22 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
814,561,152.66 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
12,371,955.60 |
| Other Current Assets |
71,251,418.72 |
| Total Current Assets |
6,183,260,392.06 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
222,624,173.88 |
| Long-term Equity Investment |
52,889,952.61 |
| Investment Properties |
-- |
| Fixed Assetes |
1,877,622,873.78 |
| Under-construction Projects |
988,594,485.67 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
525,201,222.71 |
| R&D expenses |
-- |
| Goodwill |
1,614,721,190.32 |
| Long-Term Deferred and Prepaid Expenses |
5,201,700.88 |
| Deferred Income Tax Assets |
984,796,511.88 |
| Other Non-Current Assets |
2,460,859,571.33 |
| Sub-Total of Non-Current Assets |
8,756,953,880.39 |
| Total Assets |
14,940,214,272.45 |
| Short-Term Loans |
1,200,456,369.83 |
| Trading Financial liabilities |
-- |
| Notes Payable |
250,383,661.32 |
| Accounts Payable |
1,862,225,406.02 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
560,821,183.09 |
| Taxes Payable |
860,560,657.26 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,036,326,196.88 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
350,024,101.19 |
| Other Current Liabilities |
10,524,394.12 |
| Sub-Total of Current Liabilities |
8,279,291,372.30 |
| Long-term Loans |
219,300,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
283,030,705.91 |
| Deferred Income Tax Liabilities |
15,368,289.42 |
| Other Non-Current Liabilities |
8,706,873.49 |
| Sub-Total of Non-Current Liabilities |
664,609,867.49 |
| Total Liabilities |
8,943,901,239.79 |
| Paid-In Capital(Or Share Stock) |
1,778,304,619.40 |
| Capital Surplus |
4,801,292,897.05 |
| Surplus Reserve |
506,814,877.32 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,466,319,567.72 |
| Minority Stockholder's Interest |
371,545,524.81 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,624,767,507.85 |
| Owner's Equity（Stockholder's Equity） |
5,996,313,032.66 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,940,214,272.45 |
